Evaluation of the immune status in patients with breast carcinoma
Armellino, F.; Malanetto, C.; Girotto, M.; Rossetto, P.; Francisco, G.
Minerva Ginecologica 38(10): 811-814
1986
ISSN/ISBN: 0026-4784 PMID: 3808412 Document Number: 284184
Document emailed within 1 workday
Related Documents
Gava, A.; Fontan, L.; Marazzato, G.; De Angeli, S. 1990: Multitest evaluation of the immune status of patients with bronchogenic carcinoma before and after radiotherapy Minerva Medica 81(3): 135-138Palencia, C.; Wicke, L.; Kärcher, K.H.; Gitsch, E.; Hernuss, P.; Steffen, C. 1976: Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation Wiener Klinische Wochenschrift 88(15): 495-501
Jansen, H.M.; Esselink, M.T.; Orie, N.G.; The, T.H. 1979: Cell-mediated immune response in patients with bronchial carcinoma. Relation between clinical parameters and various immunological tests for immune status investigation Netherlands Journal of Medicine 22(1): 1-9
Springer, G.F.; Desai, P.R.; Fry, W.A.; Goodale, R.L.; Shearen, J.G.; Scanlon, E.F. 1983: T antigen, a tumor marker against which breast, lung and pancreas carcinoma patients mount immune responses Cancer Detection and Prevention 6(1-2): 111-118
Ludwig, C.; Hartmann, D.; Landmann, R.; Wesp, M.; Rosenfelder, G.; Stucki, D.; Buser, M.; Obrecht, J.P. 1983: Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis Schweizerische Medizinische Wochenschrift 113(50): 1908-1911
Jovicic-Milentijevic, M.; Tokic, T.; Zivkovic, N.; Dencic, T. 2011: Simplified scoring system predicting HER-2 status in patients with breast carcinoma Journal of BUON: Official Journal of the Balkan Union of Oncology 16(3): 444-449
Thanakit, V.; Sampatanukul, P.; Ruangvejvorachai, P.; Keelawat, S. 2005: The association of co-expression of CD44v4/MMP-9 with different nodal status in high-grade breast carcinoma patients Journal of the Medical Association of Thailand 88 Suppl. 4: S30-S35
Nishio, S.; Asakawa, M.; Tanaka, S.; Wada, S.; Maekawa, M.; Kawamura, M. 1986: Studies on the cellular immune response in patients with urinary bladder carcinoma. XI: Evaluation of specific ADCC activity Hinyokika Kiyo. Acta Urologica Japonica 32(5): 713-720
Holder, W.D.; Wells, S.A. 1983: Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma Cancer Research 43(1): 239-244
Start, R.D.; Cross, S.S.; Smith, J.H. 1992: Correspondence re: G. J. Laroye and S. Minkin. The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status. Mod Pathol 4:456, 1991 Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 5(1): 95-96
Reynier, J.; Bazin, J.C.; Bizzini, B.; Gandrille, C.; Guettier, C.; Henocq, E.; Hollmann, K.; Mogenet, M.; Pompidou, A.; Santus, J.P.; Verley, J.M.; Villet, R. 1980: Carcinoma of the breast. Immune behaviour. Immunostimulation by fraction P40 Chirurgie; Memoires de l'Academie de Chirurgie 106(1): 48-55
Chandra, M.; Saxena, V.K.; Chander, S.; Sachdeva, S.; Saxena, H.M.; Ghosh, D. 1986: The effects of radiotherapy on immune status in carcinoma of the uterine cervix Indian Journal of Pathology and Microbiology 29(1): 37-43
Kalogeraki, A.; Tzardi, M.; Datseris, G.; Kanavaros, P.; Karvelas, C.; Chalkiadakis, G.; Tsiftsis, D.; Delides, G. 1994: Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases In Vivo 8(6): 1053-1056
Dutta, A.K.; Singhal, P.K.; Khare, S.; Kumari, S.; Mathur, R.; Mullick, D.N. 1989: Immune status following measles vaccination in infants and evaluation for the need of revaccination Indian Pediatrics 26(8): 765-772
Totolian, A.A.; Freĭdlin, I.S.; Shamkova, N.V. 1987: Improving the technology of 1st-order evaluation tests of immune status Laboratornoe Delo 11: 863-867
Moore, M.; Ghosh, A.K.; Jones, D.J. 1989: MHC status of primary human colorectal carcinoma: biological significance and implications for host immune recognition Acta Chirurgica Scandinavica. Supplementum 549: 17-25
Lebedev, K.A.; Poniakina, I.D. 1992: Evaluation of human immune status during changes of dwelling place (ecologic immunology) Fiziologiia Cheloveka 18(5): 72-83
Friedman, D.; Sorice, G.; Baccini, P.; Varcada, M.; Percoco, P.; Bachi, V. 1999: In situ ductal carcinoma of the breast: current status and our experience Annali Italiani di Chirurgia 70(1): 37-43; discussion 44
Shestak, K.C.; Johnson, R.R.; Greco, R.J.; Williams, S.L. 1993: Partial mastectomy and breast reduction as a valuable treatment option for patients with macromastia and carcinoma of the breast Surgery Gynecology and Obstetrics 177(1): 54-56
Dijkstra, R. 1988: Breast-preserving treatment in patients with stage i and Ii breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 132(44): 2034-2035